Norrie Russell has joined Invitrogen as vice president and general manager of its functional genomics strategic business unit, the company said last week. In this role, Invitrogen said, Russell will lead the company’s genomics, proteomics, and RNAi product lines.
Most recently, he was president and CEO of Aviva Biosciences. Prior to that, he was president and CEO of Lynx Therapeutics. Russell holds a PhD in physiology from Glasgow University in Scotland.